Stay updated on Vilazodone Safety in GAD: Clinical Trial
Sign up to get notified when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.

Latest updates to the Vilazodone Safety in GAD: Clinical Trial page
- Check5 days agoChange DetectedThe page shows a new Revision: v3.6.5, replacing the prior v3.6.4, indicating a site version update rather than a change to study information.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a small update to the page's version information.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page's revision line now shows version 3.6.3, replacing 3.6.2. This indicates a software release update for the page.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page now shows revision v3.6.2 in place of the previous v3.6.0, indicating a backend/UI update. This change does not modify the study information presented on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedRecruitment status updated to not enrolling. The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label, while replacing the older label (Intervention / Treatment) and updating the revision tag to v3.6.0.SummaryDifference0.3%

- Check70 days agoChange DetectedThe page footer revision label was updated from v3.5.4 to v3.5.5, indicating a maintenance or version update of the site. This change does not modify the study details, eligibility, or data presented on the page.SummaryDifference0.0%

Stay in the know with updates to Vilazodone Safety in GAD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.